SEARCH

SEARCH BY CITATION

References

  • 1
    American Cancer Society: Laetrile: Background information. New York. American Cancer Society, 1977.
  • 2
    United States Food and Drug Administration: Laetrile, A Commissioner's Decision. Washington, DC, Department of Health, Education and Welfare. Food and Drug Administration, 1978.
  • 3
    Dorr RT, Paxinos J: The current status of laetrile. Ann Intern Med 89: 389397, 1978.
  • 4
    Herbert VD: Laetrile: The cult of cyanide: Promoting poison for profit. Am J Clin Nutr 32: 11211158, 1979.
  • 5
    Wilson B: The rise and fall of laetrile. Nutrition Forum 5 (5): 3340, 1988.
  • 6
    Young JH: Laetrile in historical perspective, in MarkleGE, PetersenJC (eds): Politics, Science and Cancer: The Laetrile Phenomenon. Boulder. Colo, Westview Press, Inc, 1980.
  • 7
    Fenselau C, Pallante S, Batzinger RP, et al: Mandelonitrile beta-glucuronide: Synthesis and characterization. Science 198: 625627, 1977.
  • 8
    Jee J, Yoshikawa F, Pont L, et al: Assay of amygdalin dosage forms from Mexico. J Pharm Sci 67: 438440, 1978.
  • 9
    Greenberg DM: The case against laetrile: The fraudulent cancer remedy. Cancer 45: 799807, 1980.
  • 10
    Krebs ET Jr: The nitrilosides (vitamin B17): Their nature, occurrence, and metabolic significance. J Appl Nutr 22: 7586, 1970.
  • 11
    Herbert VD: Pseudovitamins, in ShilsME, YoungVR (eds): Modern Nutrition in Health and Disease, Seventh Edition, Philadelphia, Lea & Febiger, 1988, pp471477.
  • 12
    Greenberg DM: The vitamin fraud in cancer quackery. West J Med 122: 345348, 1975.
  • 13
    National Cancer Institute: Chronology of National Cancer Institute studies of laetrile. Press release. National Cancer Institute. Bethesda, Md, April 30, 1981.
  • 14
    Wodinsky I, Swiniarski JK: Antitumor activity of amygdalin MF (NSC-15780) as a single agent and with beta-glucosidase (NSC-128056) on a spectrum of transplantable rodent tumors. Cancer Chemother Rep 59: 939950, 1975.
  • 15
    Laster WR Jr. Schabel FM Jr: Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056). Cancer Chemother Rep 59: 951965, 1975.
  • 16
    Hill GJ H, Shine TE, Hill HZ, Miller C: Failure of amygdalin to arrest B16 melanoma and BW-5147 AKR leukemia. Cancer Res 36: 21022107, 1976.
  • 17
    Stock CC, Tarnowski GS, Schmid FA, et al: Antitumor tests of amygdalin in transplantable animal tumor systems. J Surg Oncol 10: 8188, 1978.
  • 18
    Stock CC, Martin DS, Sugiura K, et al: Antitumor tests of anygdalin in spontaneous animal tumor systems. J Surg Oncol 10: 89123, 1978.
  • 19
    Ovejera AA, Houchens DP, Barker AD, Vinditti JM: Inactivity of DL-amygdalin against human breast and colon tumor xenografts in athymic (nude) mice. Cancer Treat Rep 62: 576578, 1978.
  • 20
    Relman AS: Laetrilomania—again (letter). N Engl J Med 298: 215216, 1978.
  • 21
    Ellison NM, Byar DP, Newell GR: Special report on Laetrile: The NCI Laetrile review: Results of the National Cancer Institute's retrospective Laetrile analysis. N Engl J Med 299: 549552, 1978.
  • 22
    Moertel CG, Ames MM, Kovach JS, et al: A pharmacologic and toxicological study of amygdalin. JAMA 245: 591594, 1981.
  • 23
    Moertel CG: Laetrile (letter). N Engl J Med 307: 120121, 1982.
  • 24
    Moertel CG, Fleming TR, Rubin J, et al: A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med 306: 201206, 1982.
  • 25
    Braico KT, Humbert JR, Terplan KL, Lehotay JM: Laetrile intoxication: Report of a fatal case, N Engl J Med 300: 238240, 1979.
  • 26
    Ortega JA, Creek JE: Acute cyanide poisoning following administration of Laetrile enemas (letter). J Pediatr 39: 1059, 1978.
  • 27
    Hall AH, Linden CH, Kulig KW, Rumack BH: Cyanide poisoning from laetrile ingestion: Role of nitrite therapy. Pediatrics 78: 269272, 1986.
  • 28
    Smith FP, Butler TP, Cohan S, Schein PA: Laetrile toxicity: A report of two cases. Cancer Treat Rep 62: 169171, 1982.
  • 29
    Barnett RC, Pointer J, Nimitz J, Beers R: Subacute laetrile intoxication (letter). West J Med 134: 170172, 1981.
  • 30
    Morse DL, Boros L, Findley PA: More on cyanide poisoning from laetrile (letter). N Engl J Med 301: 892, 1979.
  • 31
    Kalyanaraman UP, Kalyanaraman K, Cullinan SA, McLean JM: Neuromyopathy of cyanide intoxication due to “ laetrile” (amygdalin). Cancer 51: 21262133, 1983.
  • 32
    Willhite CC: Congenital malformations induced by laetrile. Science 215: 15131515, 1982.
  • 33
    Janssen W: The courts, terminal patients, and unapproved drugs. FDA Consumer 13: 47, 1979.
  • 34
    Cassileth BR: Sounding boards: After laetrile, what?. N Engl J Med 306: 14821484, 1982.
  • 35
    Fink JM: Third Opinion: An International Guide to Alternative Therapy Centers for the Treatment and Prevention of Cancer. Garden City Park, NY. Avery Publishing Group, Inc. 1988.